Correspondence on ‘Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients’

By sjmartinez • September 21, 2023

Kermani TA. Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'. Ann Rheum Dis. 2023 Oct;82(10):e214. doi: 10.1136/annrheumdis-2021-219879. Epub 2021 Jan 21. PMID: 33478954.

Tags: biological therapy, covid-19, Publications, Rheumatology, systemic vasculitis

Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma

Lao CD, Moon J, Ma VT, Fruehauf JP, Flaherty LE, Bury MJ, Martin WG, Gross H, Akerley W, Hopkins JO, Patel SP, Sondak VK, Ribas[...]

The interventional esophagologist: tunneling a new way forward

Skef W, Kolb JM, Samo S, Legget CL, Otaki F, Konda VJA. The interventional esophagologist: tunneling a new way forward. Dis Esophagus. 2024 Sep 28:doae078.[...]

Assessing Healthcare Transition Readiness in Adolescents with Asthma through a Portal-Based Initiative

Tsevat RK, Ma J, Duan S, Chen L, Tarn DM, Ross MK. Assessing Healthcare Transition Readiness in Adolescents with Asthma through a Portal-Based Initiative. J[...]